Report of Foreign Issuer (6-k)
May 31 2018 - 08:33AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE
13a-16
or 15d-16
UNDER THE SECURITIES EXCHANGE
ACT
of 1934
For
the Month of May 2018
001-37521
(Commission
File Number)
INTEC
PHARMA LTD.
(Translation
of registrant’s name into English)
12
Hartom Street
Har
Hotzvim, Jerusalem 9777512, Israel
(+972)
(2) 586-4657
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual reports under cover
Form
20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(l): _________
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(7): _________
EXPLANATORY
NOTE
On
May 31, 2018, Intec Pharma Ltd. issued a press release titled “Intec Pharma to Present at Jefferies 2018 Healthcare Conference.”
A
copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
INTEC
PHARMA LTD.
|
|
|
|
|
|
|
By:
|
/s/
Nir Sassi
|
|
|
|
Name:
Nir Sassi
|
|
|
|
Title:
Chief Financial Officer
|
|
|
|
Date:
May 31, 2018
|
|
|
|
EXHIBIT
INDEX
Intec Parent (NASDAQ:NTEC)
Historical Stock Chart
From Feb 2024 to Mar 2024
Intec Parent (NASDAQ:NTEC)
Historical Stock Chart
From Mar 2023 to Mar 2024